Tag: AstraZeneca
AstraZeneca to stop developing Crohn’s disease drug
British drugmaker AstraZeneca said on Thursday (June 1) it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative...
AstraZeneca confident new COVID antibody protects against known variants
British drugmaker AstraZeneca says it's confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants.
Laboratory studies...
AstraZeneca boosts heart, kidney business with $1.8 bln CinCor deal
Anglo-Swedish drugmaker AstraZeneca said on Monday (January 9) that it had struck a deal to buy US-based drug developer CinCor Pharma for up to $1.8...
AstraZeneca boosts cancer portfolio with $320 mln Neogene deal
Pharmaceutical giant AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday (November 29) as it seeks...
UK’s C4X Discovery signs $400m deal with AstraZeneca to develop treatment of respiratory diseases
British drug discovery company C4X Discovery said AstraZeneca had signed a licence worth up $402 million to develop an oral therapy for the treatment of inflammatory...
India gets ready to start administering Covid mix-and-match booster vaccines
Health authorities in India have said that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken...